Karyopharm Therapeutics I...

4.08
0.22 (5.70%)
At close: Apr 07, 2025, 3:59 PM
4.21
3.19%
Pre-market: Apr 08, 2025, 09:01 AM EDT

Karyopharm Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
145.24M 146.03M 157.07M 209.82M 108.08M 40.89M 30.34M 1.6M 154K
6.01M 4.94M 5.21M 3.4M 2.71M 2.41M 161.37M 107.27M 86.94M
139.23M 141.09M 151.86M 206.42M 105.38M 38.49M -131.04M -105.67M -86.78M
-119.44M -129.54M -142.2M -98.27M -171.85M -189.28M -179.88M -130.54M -110.73M
7.4M 10.94M 2.36M 582K 2.82M 5.42M 4.03M 1.7M 1.28M
-76.36M -142.78M -164.92M -123.82M -195.96M -199.55M -178.38M -128.92M -109.44M
-76.42M -143.1M -165.29M -124.09M -196.27M -199.59M -178.41M -128.98M -109.58M
115.44M 131.88M 145.4M 143.85M 126.42M 105.42M 48.85M 24.87M 23.95M
143.23M 138.75M 148.66M 160.84M 150.81M 122.34M 161.37M 107.27M 86.94M
n/a n/a -83K -85K 206K -50K -33K -81K 10K
258.67M 270.63M 294.06M 304.69M 277.23M 227.76M 210.22M 132.14M 110.89M
37.42M 23.82M 25M 26.05M 27.14M 15.65M 2.49M n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
264.68M 275.57M 299.28M 308.09M 279.94M 230.17M 210.22M 132.14M 110.89M
57K 323K 369K 268K 309K 40K 26K 63K 139K
121.86M 114.22M 81.87M 75.22M 72.04M 61.96M 56.78M 45.9M 37.52M
126.81M 114.22M 81.87M 75.22M 72.04M 61.96M 56.78M 45.9M 37.52M
-0.63 -1.25 -2.02 -1.65 -2.72 -3.22 -3.14 -2.81 -2.92
-0.6 -1.25 -2.02 -1.65 -2.72 -3.22 -3.14 -2.81 -2.92
-38.6M -118.42M -139.31M -96.98M -167.85M -182.93M -175.15M -128.21M -108.72M
-38.94M -118.95M -139.93M -97.77M -168.82M -183.9M -175.89M -128.92M -109.44M
340K 530K 621K 789K 972K 974K 735K 713K 717K